References
- Carev M, Kovačić A, Novak A, et al. Campylobacter jejuni strains coresistant to tetracycline and ciprofloxacin in patients with gastroenteritis in Croatia. Infect Dis (Lond). 2017;49:268–276.
- BSAC Susceptibility Testing Method – History [Internet]. London (UK): British Society for Antimicrobial Chemotherapy, BSAC; 2017. [cited 2017 Apr 4]. Available from: http://www.bsac.org.uk/stewardship-surveillance/susceptibility/bsac-susceptibility-testing-method-history/
- Antimicrobial susceptibility testing [Internet]. Växjö (Sweden): European Committee on Antimicrobial Susceptibility Testing, EUCAST; 2017. [cited 2017 Apr 4]. Available from: http://www.eucast.org/ast_of_bacteria/previous_versions_of_documents/
- EFSA and ECDC. The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2014. EFSA J. 2016;14:4380.
- Uzunović-Kamberović S, Zorman T, Berce I, et al. Comparison of the frequency and the occurrence of antimicrobial resistance among C. jejuni and C. coli isolated from human infections, retail poultry meat and poultry in Zenica-Doboj Canton, Bosnia and Herzegovina. Med Glas. 2009;6:173–180.
- Talsma E, Goettsch WG, Nieste HLJ, et al. Resistance in Campylobacter species: increased resistance to fluoroquinolones and seasonal variation. Clin Infect Dis. 1999;29:845–848.
- Van Hees BC, Veldman‐Ariesen MJ, De Jongh BM, et al. Regional and seasonal differences in incidence and antibiotic resistance of Campylobacter from a nationwide surveillance study in the Netherlands: an overview of 2000–2004. Clin Microbiol Infect. 2007;13:305–310.
- CDC [Internet]. National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS): Human Isolates Final Report, 2013. Atlanta, Georgia: U.S. Department of Health and Human Services, CDC; 2015. [cited 2017 April 4]. Available from: https://www.cdc.gov/narms/pdf/2013-annual-report-narms-508c.pdf
- Zhou J, Zhang M, Yang W, et al. A seventeen-year observation of the antimicrobial susceptibility of clinical Campylobacter jejuni and the molecular mechanisms of erythromycin-resistant isolates in Beijing, China. Int J Infect Dis. 2016;42:28–33.
- Gelband H, Molly Miller P, Pant S, et al. The state of the world’s antibiotics 2015. WHSA. 2015;8:30–34.